EU-Kommission: Zulassung von Imvanex gegen Affenpocken

 

 

Bavarian Nordic monkeypox vaccine wins EU approval | Reuters

Danish biotechnology company Bavarian Nordic said on Monday the European Commission had given permission for its Imvanex vaccine to be marketed as protection against monkeypox, as recommended last week by the European Medicines Agency (EMA).